发明名称 NOVEL LIGANDS OF NUCLEAR RECEPTOR
摘要 It has been newly found out that ascochlorin, which is a publicly known fat- soluble antibiotic, and its homologs serve as a ligand of retinoid X recepto r and react in vivo with the amino group of serum protein to form Schiff bases without showing any side effect of retinoid. Ascochlorin and its homologs ar e usable in treating and/or preventing diseases or conditions which can be relieved by the retinoid X receptor ligand-dependent gene signal transcriptional regulation (for example, diseases caused by the expression o f insulin resistance, hypertension, cerebrovascular diseases, rheumatoid arthritis, autoimmune diseases, Ca metabolic error, complication of diabetes , arteriosclerosis, etc.). Moreover, they can inhibit denaturation and/or necrosis of pancreatic Langerhans islet .beta.-cells and, therefore, are usable in making these cells to sustain the insulin productivity.
申请公布号 CA2355299(A1) 申请公布日期 2000.06.22
申请号 CA19992355299 申请日期 1999.12.14
申请人 NUCLEAR RECEPTOR RESEARCH LIMITED 发明人 TAMURA, GAKUZO;ANDO, KUNIO;MAGAE, JUNJI;UCHIDA, TAKAFUMI
分类号 A61K31/12;A61K31/192;A61K31/216;A61K31/353;A61K31/455;A61P3/10;A61P9/10;A61P19/02;A61P37/00;A61P37/06;C07C403/20;C07C403/24;C07D213/79;C07D213/80;C07D311/58;C07D311/70;(IPC1-7):C07C403/20;A61P9/12;A61P3/14;C07K14/47 主分类号 A61K31/12
代理机构 代理人
主权项
地址